Pfizer Settles Fee Dispute In $785M FCA Deal
By Brian Amaral · May 10, 2017, 2:53 PM EDT
Pfizer Inc. and a relator who blew the whistle on false claims have agreed to resolve their dispute over how much in attorneys' fees the company should pay after its $785...
To view the full article, register now.